Brad Scrivner

Brad Scrivner is an accomplished Senior Area Business Leader at Eisai US, specializing in Neurology Specialty Sales since March 2020, with a focus on the South Central District. Brad has a proven track record in pharmaceutical sales and leadership roles, having previously served as Senior Division Alliance Manager and Senior District Manager at Eisai, where notable achievements include leading the co-promote launch of Aduhelm for Alzheimer’s treatment and expanding the epilepsy sales force. Prior experience includes significant positions at Lundbeck, Sunovion Pharmaceuticals, Ipsen Biopharmaceuticals, and Novartis, characterized by successful sales growth strategies and multiple awards for sales performance. Brad holds a B.S. in Psychology from Arkansas State University.